Search Results

And it almost always starts with one skipped step: the strategy workshop. How a 45-Minute Strategy Workshop Changes the Game The idea of a “strategy workshop” often sounds like the team’s energy. 👉 Most importantly, a strategy workshop replaces drift with momentum. From Chaos to Clarity: Embedding Strategy in Daily Decisions 👉 A one-off workshop can create alignment That’s what a strategy workshop does. It takes just 45 minutes.

Patent strategy review is not about protecting the past. Why Patent Strategy Review Matters at the Start of the Year The beginning of the year is when strategic Narratives are still forming. ✅ This is why smart biotech CEOs use the patent strategy review as a proactive , science and strategy advance together . Smart biotech CEOs understand that strategy is not a document.

The AI Buzz Is Real But So Is the Strategy Gap 👉 AI is dominating the biotech conversation right now AI moves you forward, but strategy ensures you’re on the right path. In practice,  AI models built on messy or irrelevant data can produce misleading results or even regulatory Why Strategy Still Decides Outcomes Even the most sophisticated AI cannot fix a weak strategy.   It’s strategy that delivers real results.  

A Simple Framework: The Three Levers of Licensing Strategy Think of your licensing agreement as three In practice: Clean chain-of-title Clear rights to improvements No ambiguous “jointly owned results” language In practice: Fields of use that leave headroom Reversion terms that don’t create existential threats In practice: Royalties that don’t exceed pharma norms Milestones achievable without heroic funding No Attila runs focused strategy consultations for biotech founders who are ready to lead with clarity, not

. 👉 Science and strategy slowly stop talking to each other in meaningful moments.   It weakens when science and strategy are no longer part of the same decisions. Strategy focuses on survival. Both are acting rationally within unclear boundaries. Workshops, values, and good intentions help, but they do not create shared decision moments.   It is a strategic choice. When science and strategy disconnect, collaboration weakens.

outputs to business outcomes  — not just feasibility, but commercial relevance You can explain your strategy Strategy Advantage: Why Clarity Wins This is where the strategy advantage  becomes clear. When your strategy is clear, investors notice. That’s what strategy is. Attila runs focused strategy consultations for biotech founders  who are ready to lead with clarity,

✅ This step is where strategy becomes real. . 👉 Step 3: Set micro-commitments with real ownership Strategy only matters if it leads to action. Strategy Means Nothing If Your Team Can’t See It Most SME leaders carry a strategy in their heads. You also send a clear message that strategy is not a leadership activity. Finish Strong and Start Sharper. 👉 Most SME strategies die in silence.  

. ✅ SME hiring strategy is not about scaling fast. . 👉 This article challenges the default of urgency-based hiring and offers a practical, strategic lens But without a strategy, it’s just motion without direction. That’s what strategic hiring enables, not just more capacity, but more leadership Your Strategy Safety clarity and culture benchmarks, you spot early whether someone truly fits — not just on paper, but in practice

. 👉 This is where the biotech focus strategy  becomes misunderstood. A clear biotech focus strategy allows teams to say this with confidence. What High-Performing Biotechs Do Differently in Practice High-performing biotechs do not rely on intuition choices after they are made. 👉 These practices create a powerful effect. Strategic Takeaway 👉 A biotech focus strategy is not about limiting your future.

But here’s the truth: AI is not a strategy.  It's a tool. "AI in biotech strategy: Use it as a tool, not a crutch" The Reality of AI in Biotech Strategy Let’s “AI in biotech strategy only creates value when it's aligned with your scientific and business milestones But unless you’ve anchored your biotech strategy in a real-world problem — a patient need, a technical Attila runs focused strategy consultations for biotech founders  who are ready to lead with clarity,

For many biotech founders, the idea of delegation feels obvious in theory but nearly impossible in practice Founders often see delegation as a form of relief , not as a strategy.   But in practice, this approach often creates more problems than it solves. Treating it as a strategy will unlock a path to scale. But they should not be tasked with visionary strategy or creative business development.

Ethics and strategy. Turning Principles Into Practice: Real-World Actions Here’s what it looks like when ethics moves from paper to practice: ✅ Ethics Impact Assessments : Similar to environmental reviews, these evaluate These practices don’t slow you down, they make your organization faster, more resilient, and more fundable It’s engineered, through clear decisions, proactive governance, and a deliberate biotech ethics strategy